This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wenzel, U. O. Articles by Schwietzer, G. Search for Related Content PubMed PubMed Citation Articles by Wenzel, U. O. Articles by Schwietzer, G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ENALAPRIL MALEATE

Hypertension, Vol 20, 233-241, Copyright © 1992 by American Heart Association

ARTICLES

Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension

UO Wenzel, G Troschau, W Schoeppe, U Helmchen and G Schwietzer
Department of Medicine, University of Frankfurt am Main, FRG.

The effect of a 6-week treatment with the calcium channel blocker nitrendipine or the angiotensin converting enzyme inhibitor enalapril on blood pressure, albuminuria, renal hemodynamics, and morphology of the nonclipped kidney was studied in rats with two-kidney, one clip renovascular hypertension. Six weeks after clipping of one renal artery, hypertensive rats (178 +/- 4 mm Hg) were randomly assigned to three groups: untreated hypertensive controls (n = 8), enalapril- treated (n = 8), or nitrendipine-treated (n = 10). Sham-operated rats served as normotensive controls (128 +/- 3 mm Hg, n = 8). After 6 weeks of treatment, renal hemodynamics (glomerular filtration rate and renal plasma flow) were measured in the anesthetized rats. Renal tissue was obtained for determination of glomerular size and sclerosis. Enalapril but not nitrendipine reduced blood pressure significantly. After 6 weeks of therapy, glomerular filtration rate was not different among the studied groups. Renal plasma flow increased, but albumin excretion and glomerulosclerosis did not change after enalapril treatment. In contrast, in the nitrendipine-treated group albuminuria increased from 12.8 +/- 2 progressively to 163 +/- 55 compared with 19.2 +/- 9 mg/24 hr in the hypertensive controls. Furthermore, glomerulosclerosis index was significantly increased in the nitrendipine-treated group compared with the hypertensive controls (0.38 +/- 0.1 versus 0.13 +/- 0.04). In addition, glomerular size was higher in the nitrendipine-treated group (14.9 +/- 0.17 10(-3) mm2) but lower in the enalapril-treated group (11.5 +/- 0.15 10(-3) mm2) compared with the hypertensive controls (12.1 +/- 0.17 10(-3) mm2).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S. Fujimoto, M. Satoh, H. Nagasu, H. Horike, T. Sasaki, and N. Kashihara Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3651 - 3658. [Abstract] [Full Text] [PDF]

				D. Son, I. Kojima, R. Inagi, M. Matsumoto, T. Fujita, and M. Nangaku Chronic hypoxia aggravates renal injury via suppression of Cu/Zn-SOD: a proteomic analysis Am J Physiol Renal Physiol, January 1, 2008; 294(1): F62 - F72. [Abstract] [Full Text] [PDF]

				O. M. Steinmetz, U. Panzer, S. Fehr, C. Meyer-Schwesinger, R. A. K. Stahl, and U. O. Wenzel A pitfall of glomerular sieving: profibrotic and matrix proteins derive from the Bowman's capsule and not the glomerular tuft in rats with renovascular hypertension Nephrol. Dial. Transplant., October 1, 2007; 22(10): 3055 - 3060. [Abstract] [Full Text] [PDF]

				K. Hayashi, S. Wakino, N. Sugano, Y. Ozawa, K. Homma, and T. Saruta Ca2+ Channel Subtypes and Pharmacology in the Kidney Circ. Res., February 16, 2007; 100(3): 342 - 353. [Abstract] [Full Text] [PDF]

				O. M. Steinmetz, S. Sadaghiani, U. Panzer, C. Krebs, C. Meyer-Schwesinger, T. Streichert, S. Fehr, I. Hamming, H. van Goor, R. A. K. Stahl, et al. Antihypertensive therapy induces compartment-specific chemokine expression and a Th1 immune response in the clipped kidney of Goldblatt hypertensive rats Am J Physiol Renal Physiol, February 1, 2007; 292(2): F876 - F887. [Abstract] [Full Text] [PDF]

				G. Wolf Zenon's paradox or how much to lower blood pressure for optimal renoprotection Nephrol. Dial. Transplant., November 1, 2005; 20(11): 2304 - 2307. [Full Text] [PDF]

				U. O. Wenzel, G. Wolf, I. Jacob, C. Schwegler, A. Qasqas, K. Amann, U. Helmchen, and R. A. K. Stahl Beneficial and adverse renal and vascular effects of the vasopeptidase inhibitor omapatrilat in renovascular hypertensive rats Nephrol. Dial. Transplant., October 1, 2003; 18(10): 2005 - 2013. [Abstract] [Full Text] [PDF]

				F. I. Kvam, J. Ofstad, and B. M. Iversen Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR Am J Physiol Renal Physiol, October 1, 1998; 275(4): F576 - F584. [Abstract] [Full Text] [PDF]

				R. Slataper, N. Vicknair, R. Sadler, and G. L. Bakris Comparative Effects of Different Antihypertensive Treatments on Progression of Diabetic Renal Disease Arch Intern Med, April 26, 1993; 153(8): 973 - 980. [Abstract] [PDF]